Tags100 prescribers

Updated guidelines for PEP (Post-Exposure Prophylaxis) after non-occupational and occupational exposure to HIV 

U

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV .  These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...

Monkeypox update: Vaccine appointments in SA / Clinical Guidance / Information for GBMSM / Podcast

M

1. Monkeypox Virus Vaccine in South Australia SHINE SA, 11th August 2022 The situation with monkeypox virus and vaccine availability is changing quickly. Limited monkeypox (MPX) vaccine appointments are now available in SA. As there is currently very limited supply of MPX Vaccine in SA, SHINE SA have been advised by SA Health that until further notice, eligibility is limited to people who meet...

Update: Changes to HIV treatment access for people ineligible for Medicare

U

NAPWHA, ASHM, AFAO,  May 2022 From 1st July, people with HIV who are ineligible for Medicare, and who previously received HIV medication through compassionate access schemes, will be required to transition to alternative access arrangements in order to receive government-funded treatment*. Option 1: individuals will need to engage in care with a public hospital-based physician and have their...

Nurse Practitioner (s100) Prescribing Change

N

Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...

Information about TRUVADA and ATRIPLA delisting

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

HIV PrEP update & HIV prescriber update in Adelaide

H

ASHM, October 2018 HIV PrEP Update for GPs and Practice Nurses This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP). – Date Tuesday, 23 October 2018 – Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA...

Your sidebar area is currently empty. Hurry up and add some widgets.